‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
The independent source for health policy research, polling, and news.
181 - 200 of 232 Results
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Although deaths from colorectal cancer are declining, researchers find rates of the disease among white men and women younger than 55 have spiked since the mid-1990s.
Thinking they were protected from insurance discrimination, many people got tested to see if they were likely to develop serious diseases. Legislation pushed by Republican leaders in Congress would leave them vulnerable.
Among hurdles: Older adults may have multiple illnesses that could complicate research or they might be unable to manage the commute.
As we get older, it helps to tickle the noggin with trivia. Here's a pop quiz to see what you have learned as a regular reader of Kaiser Health News.
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.
Even the most exalted among us realize health care policy is complicated. Here's a pop quiz to see what you have learned as a regular reader of Kaiser Health News.
Hospitals and oncology practices are setting up urgent care services aimed specifically at cancer patients to help keep them out of the hospital.
Doctors and drug developers have a stake in making cancer treatments seem better than they really are.
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
Researchers believe Californians, many of whom lost health coverage, delayed doctor visits that could have led to earlier detection. Now, with people seeking medical care under the Affordable Care Act, some experts expect to see an increase in late-stage cancers.
Lung cancer screening rates have not changed much even though the U.S. Preventive Services Task Force has recommended that smokers get checked, according to a new study.
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
A bill recently introduced in the California legislature would require insurance companies to cover fertility-preserving services for patients at risk of infertility because of necessary medical treatments.
Effort asks salon owners to voluntarily improve air quality and use less toxic chemicals.
Mammograms find many slow-growing cancers that aren’t life-threatening and shouldn’t be treated, a Danish study said.
In a number of states, including big ones such as New York and Texas, leading cancer centers aren’t included in insurers’ provider networks.
Removing them during already-planned hysterectomies poses little risk and can help prevent a deadly cancer, researchers find.
A new study shows women fare worse without a support network.
© 2026 KFF